Tvardi Therapeutics Inc. (TVRD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    40.23
    2.86 (7.65%)
    At close: Oct 03, 2025, 3:59 PM
    40.22
    -0.02%
    Pre-market: Oct 06, 2025, 07:52 AM EDT

    Tvardi Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.11 -2.64 -2.23 -0.08
    PEG Ratio
    		 -0.00 0.17 0.02 0.00
    PS Ratio
    		 1.04 2.19 1.09 0.30
    PB Ratio
    		 -1.62 -0.74 -1.02 0.03
    P/FCF Ratio
    		 -0.12 -2.18 -2.56 -0.11
    P/OCF Ratio
    		 -0.12 -2.18 -2.57 -0.11
    OCF/S Ratio
    		 -8.54 -1 -0.43 -2.61
    Debt / Equity Ratio
    		 -9.68 -0.01 -0.01 0.02
    Quick Ratio
    		 10.81 7.97 10.31 9.69
    Current Ratio
    		 11.03 7.97 10.31 9.84
    Asset Turnover
    		 0.16 0.78 0.93 0.09
    Interest Coverage
    		 -6.58 n/a -7.06K n/a
    Return on Equity
    		 15.43 0.28 0.46 -0.39
    Return on Assets
    		 -1.62 -0.64 -0.46 -0.36
    Return on Invested Capital
    		 -1.39 -0.78 -0.49 -0.39
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.89 0.69 0.82 0.93
    Net Profit Margin
    		 -9.93 -0.83 -0.49 -3.84
    Pretax Profit Margin
    		 -9.99 -0.83 -0.49 -3.84
    Operating Profit Margin
    		 -7.82 -0.89 -0.51 -3.87
    FCF Margin
    		 -8.68 -1 -0.43 -2.61
    EBITDA Margin
    		 -8.77 -0.82 -0.49 -3.77

    Add to Watchlist